Thursday, October 7, 2021

Merck slammed for 4,000% markup of taxpayer-funded COVID-19 drug - Raw Story - Celebrating 17 Years of Independent Journalism

… Heidi Chow of the Jubilee Debt Campaign decried the $700-per-patient price the U.S. government paid for molnupiravir as "another example of Big Pharma reaping billions from public investment into research by charging extortionate, rip-off prices for lifesaving Covid drugs."…


No comments:

Post a Comment








Click Older Posts above to see more.